Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: A randomized, placebo- and active-comparator-controlled clinical trial

This publication has 11 references indexed in Scilit:

• Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model
  Clinical Pharmacology & Therapeutics, 1999
• The COX-2 specific inhibitor, MK-0966, is effective in the treatment of primary dysmenorrhea
  Clinical Pharmacology & Therapeutics, 1999
• Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects
  Arthritis & Rheumatism, 1998
• CYCLOOXYGENASES AS THE PRINCIPAL TARGETS FOR THE ACTIONS OF NSAIDs
  Rheumatic Disease Clinics of North America, 1998
• Effect of NSAID administration on tissue levels of immunoreactive prostaglandin E2, leukotriene B4, and (S)-flurbiprofen following extraction of impacted third molars
  Published by Wolters Kluwer Health ,1997
• Onset of Analgesia: Further Validation of A New Stopwatch Methodology
  Clinical Pharmacology & Therapeutics, 1996
• Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.
  Journal of Biological Chemistry, 1993
• Prostaglandin endoperoxide synthase: regulation of enzyme expression
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
• The correlation between blood levels of ibuprofen and clinical analgesic response
  Clinical Pharmacology & Therapeutics, 1986
• Five Studies on Ibuprofen for Postsurgical Dental Pain
  The American Journal of Medicine, 1984